Zynerba Pharmaceuticals – Hot or Not


Zynerba Pharmaceuticals (Nasdaq:ZYNE) is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments. It has a market cap of $83.3 million, and is not profitable.. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether Zynerba Pharmaceuticals is hot or not.

Partner Content

Leveling the playing field for female entrepreneurs in Africa

By Olga Arara-Kimani, Regional Head, Corporate Affairs and Brand & Marketing Introduction Mobilising support for female...

Smart Mobility: Gautrain the sustainable way of travel!

The theme for October Transport Month 2020 is Smart Mobility.  Smart Mobility is an innovative way of getting around. it is the...

How COVID is teaching us to be better communicators

After years of having served as a senior communications practitioner, I’ve learned that the most important attribute of any effective communicator is...

Subscribe to our newsletter

Sign up for free newsletters and get more CNBC AFRICA delivered to your inbox